BidaskClub Lowers PetIQ (PETQ) to Hold
PetIQ (NASDAQ:PETQ) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.
PETQ has been the topic of several other research reports. Jefferies Group raised PetIQ from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a research note on Monday, November 20th. Zacks Investment Research lowered PetIQ from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 12th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $26.83.
PetIQ (PETQ) opened at $22.23 on Wednesday. PetIQ has a one year low of $17.03 and a one year high of $28.23. The company has a debt-to-equity ratio of 0.19, a current ratio of 6.83 and a quick ratio of 4.67.
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.